Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.

Author:

Hagemeijer F

Abstract

In 16 patients, a sustained supraventricular tachyarrhythmia occurring less than 72 hours after the first symptom of an acute myocardial infarction was treated with titrated doses of verapamil. The drug was given intravenously in 1 mg increments every minute under continuous monitoring of electrocardiogram and blood pressure. Endpoints for the administration of verapamil were the following: reversion to sinus rhythm; a ventricular rate slower than 100/min; hypotension; a pulmonary capillary wedge pressure rising above 15 mm Hg; signs of intolerance; a maximum dose of 20 mg. Reversion to sinus rhythm was observed in 7/8 patients in atrial flutter and in 1/8 patients in atrial fibrillation; in all the ventricular rate could be slowed below 100/min without untoward effects.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Atrial tachyarrhythmias in acute myocardial infarction

2. Clinical setting and prognostic significance of atrial fibrilIation complicating acute myocardial infarction;Liem KL;Europ J Cardiol,1976

3. Verapamil in lifethreatening tachyarrhythmias;Gotsman MS;S A Med J,1972

4. Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

5. Le traitement des troubles du rythme cardiaque par le verapamil. (A propos de 107 observations);Fauchier JP;Gaz Med Fr,1973

Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Calcium channel blockers;Meyler's Side Effects of Drugs;2016

2. Drugs Used to Treat Hypertension, Heart Failure, and Angina Pectoris;Meyler’s Side Effects of Cardiovascular Drugs;2009

3. Calcium channel blockers;Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions;2006

4. Adverse cardiovascular drug interactions;Current Problems in Cardiology;2000-09

5. Antiarrhythmic Agents;Current Cardiovascular Drugs;2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3